Friday 6 November 2026 Export SHC’s income statement to Excel — free account

Sotera Health Company

SHC Healthcare Diagnostics & Research

Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024.

Revenue: +4.36%
EPS: +20.1%
Free cash flow: +65.0%
Total debt: +0.14%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

15.87 0.52 −3.17%

Follow SHC

Alert me

Market cap: $4.5B
P/E: 26.3×
Fwd P/E: 26.4×
Dividend yield: —
F-score: 7/9
Altman Z: 1.76
Beneish M: −2.75
Dividend safety: n/a

Overview

Sotera Health Company (SHC) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Sotera Health Company (SHC) trades at a price to free cash flow of 33.5×. Over the past ten years it has ranged from 0.0× (June 2024) to 148× (September 2024); the current reading is higher than 32% of that period. That is in line with the Diagnostics & Research industry median of 33.5× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/SHC/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Sotera Health Company price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/SHC/metrics/price-to-free-cash-flow">Sotera Health Company (SHC) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	33.6×	(60.86%)
FY2024	85.8×	—
FY2023	0.0×	—
FY2022	24.4×	(33.41%)
FY2021	36.7×	(64.65%)
FY2020	104×	178.87%
FY2019	37.2×	0.00%
FY2018	37.2×	—

Period	Price to free cash flow	Change
Sep 2026	39.0×	(13.25%)
Jun 2026	45.0×	6.69%
Mar 2026	42.2×	25.63%
Dec 2025	33.6×	(34.91%)
24 more quarters	Free account

Against its own ten years

Low 0.0× High 148×

Ten-year median 40.8×

Current reading's percentile 32

Company	Price to free cash flow
NEO NeoGenomics, Inc. compare	n/m
GRAL GRAIL, Inc. compare	n/m
ADPT Adaptive Biotechnologies Corporation compare	n/m
VCYT Veracyte, Inc. compare	12.0×
QGEN QIAGEN N.V. compare	23.8×
SHC Sotera Health Company	33.5×
CDNA CareDx, Inc. compare	68.9×
BLLN BillionToOne, Inc. compare	156×
RDNT RadNet, Inc. compare	189×
Diagnostics & Research industry median	33.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Sotera Health Company (SHC) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on SHC

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on SHC

Stockrow Weekly